Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|5|621-632

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.5, 2007-05, pp. : 621-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat

By Stieg P.E.   Sathi S.   Warach S.   Le D.A.   Lipton S.A.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite

Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies

By  

Current Drug Targets, Vol. 2, Iss. 3, 2001-09 ,pp. : 241-271

Bentham Science Publishers

Access to resources Recommend Favorite

Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine

By Piasecki J.   Koros E.   Dyr W.   Kostowski W.   Danysz W.   Bienkowski P.  

European Journal of Pharmacology, Vol. 354, Iss. 2, 1998-08 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

S-Nitrosylation in Regulation of Inflammation and Cell Damage

By  

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1831-1838

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of memantine for neuroprotection in dementia

By Jain K.K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1397-1406

Informa Healthcare

Access to resources Recommend Favorite